Class ITerminatedD-1085-2019
Drug recall · April 3, 2019
Blue Fusion Capsules recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640, Riverside, CA 92507, UPC 7 48252 66460 0
- Lots / codes
All lots
- Quantity
- Unknown
- Company
- Ata International Inc, Orange, CA
- Distribution
- Nationwide within the United States
- Initiated
- March 14, 2019 · Voluntary: Firm initiated
- Classified
- April 9, 2019
- Reported
- April 3, 2019
- Ended
- February 27, 2023
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.